Palvella Therapeutics initiates coverage with an outperform rating
PVLA•William Blair initiated coverage of Palvella Therapeutics with an outperform rating.
Related News
William Blair initiates coverage of Arcus Biosciences with outperform rating
RCUS•
Russia takes over more EU companies' assets over Ukraine support
SON•
Wall Street futures mixed as tech wobbles again, Tesla gains
SPY•
Shell agrees sale of French mobility unit to DCC Energy, source says
SHEL•
Jardine Matheson directors, associates acquire $36.59 million in shares via scrip dividend scheme
JMHLY•